These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18379460)

  • 1. [The use of noben for correction of mitochondrial disorders in Friedrich's disease].
    Ershova MV; Illarioshkin SN; Sukhorukov VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):32-7. PubMed ID: 18379460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
    Hart PE; Lodi R; Rajagopalan B; Bradley JL; Crilley JG; Turner C; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Arch Neurol; 2005 Apr; 62(4):621-6. PubMed ID: 15824263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exonic deletions of FXN and early-onset Friedreich ataxia.
    Anheim M; Mariani LL; Calvas P; Cheuret E; Zagnoli F; Odent S; Seguela C; Marelli C; Fritsch M; Delaunoy JP; Brice A; Dürr A; Koenig M
    Arch Neurol; 2012 Jul; 69(7):912-6. PubMed ID: 22409940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylaxis of ischemic heart lesions during chronic heart failure with complex therapy using Q10 coenzyme].
    Shilov AM; Mel'nik MV; Voevodina ES; Osiia AO; Griaznov DA
    Anesteziol Reanimatol; 2011; (2):34-8. PubMed ID: 21692219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy.
    Cooper JM; Korlipara LV; Hart PE; Bradley JL; Schapira AH
    Eur J Neurol; 2008 Dec; 15(12):1371-9. PubMed ID: 19049556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up.
    Ribaï P; Pousset F; Tanguy ML; Rivaud-Pechoux S; Le Ber I; Gasparini F; Charles P; Béraud AS; Schmitt M; Koenig M; Mallet A; Brice A; Dürr A
    Arch Neurol; 2007 Apr; 64(4):558-64. PubMed ID: 17420319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Friedreich's ataxia: from disease mechanisms to therapeutic interventions.
    Lodi R; Tonon C; Calabrese V; Schapira AH
    Antioxid Redox Signal; 2006; 8(3-4):438-43. PubMed ID: 16677089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.
    Mariotti C; Fancellu R; Caldarazzo S; Nanetti L; Di Bella D; Plumari M; Lauria G; Cappellini MD; Duca L; Solari A; Taroni F
    Mov Disord; 2012 Mar; 27(3):446-9. PubMed ID: 22411849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia.
    Soriano S; Llorens JV; Blanco-Sobero L; Gutiérrez L; Calap-Quintana P; Morales MP; Moltó MD; Martínez-Sebastián MJ
    Gene; 2013 Jun; 521(2):274-81. PubMed ID: 23542074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Noben (idebenone) in the treatment of dementia and memory impairment without dementia].
    Voronkova KV; Meleshkov MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):27-32. PubMed ID: 18454094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant use in Friedreich ataxia.
    Myers L; Farmer JM; Wilson RB; Friedman L; Tsou A; Perlman SL; Subramony SH; Gomez CM; Ashizawa T; Wilmot GR; Mathews KD; Balcer LJ; Lynch DR
    J Neurol Sci; 2008 Apr; 267(1-2):174-6. PubMed ID: 17988688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the gene in Friedreich ataxia.
    Hebert MD
    Biochimie; 2008 Aug; 90(8):1131-9. PubMed ID: 18206656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GAA repeat polymorphism in Turkish Friedreich's ataxia patients.
    Yilmaz MB; Koç AF; Kasap H; Güzel AI; Sarica Y; Süleymanova D
    Int J Neurosci; 2006 May; 116(5):565-74. PubMed ID: 16644517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of idebenone.
    Becker C; Bray-French K; Drewe J
    Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1437-44. PubMed ID: 20955109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and sizing of GAA trinucleotide repeat expansion, investigation for D-loop variations and mitochondrial deletions in Iranian patients with Friedreich's ataxia.
    Houshmand M; Panahi MS; Nafisi S; Soltanzadeh A; Alkandari FM
    Mitochondrion; 2006 Apr; 6(2):82-8. PubMed ID: 16581313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
    Parkinson MH; Schulz JB; Giunti P
    J Neurochem; 2013 Aug; 126 Suppl 1():125-41. PubMed ID: 23859348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients.
    Castaldo I; Pinelli M; Monticelli A; Acquaviva F; Giacchetti M; Filla A; Sacchetti S; Keller S; Avvedimento VE; Chiariotti L; Cocozza S
    J Med Genet; 2008 Dec; 45(12):808-12. PubMed ID: 18697824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Friedreich's ataxia: coenzyme Q10 and vitamin E therapy.
    Cooper JM; Schapira AH
    Mitochondrion; 2007 Jun; 7 Suppl():S127-35. PubMed ID: 17485244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Friedreich ataxia with GAA repeat expansion: molecular mechanism and clinical feature].
    Tanaka H
    Nihon Rinsho; 1999 Apr; 57(4):960-6. PubMed ID: 10222797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
    Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
    Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.